Edition:
India

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

0.64USD
1:30am IST
Change (% chg)

$-0.01 (-1.98%)
Prev Close
$0.65
Open
$0.66
Day's High
$0.67
Day's Low
$0.64
Volume
15,757
Avg. Vol
43,248
52-wk High
$6.44
52-wk Low
$0.63

Chart for

About

ReShape Lifesciences Inc., formerly EnteroMedics Inc., is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC... (more)

Overall

Beta: 3.09
Market Cap(Mil.): $17.00
Shares Outstanding(Mil.): 8.29
Dividend: --
Yield (%): --

Financials

BRIEF-Reshape Lifesciences Reports Qtrly Loss Per Share Of $0.45‍​

* RESHAPE LIFESCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

03 Apr 2018

BRIEF-Reshape Lifesciences Announces $6 Million Registered Direct Offering

* RESHAPE LIFESCIENCES ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

02 Apr 2018

BRIEF-Reshape Lifesciences Reschedules Fourth Quarter And Full Year 2017 Conference Call To April 2, 2018

* RESHAPE LIFESCIENCES ANNOUNCES UPDATE ON INTEGRATION EFFORTS AND RESCHEDULES FOURTH QUARTER AND FULL YEAR 2017 CONFERENCE CALL TO APRIL 2, 2018

20 Mar 2018

BRIEF-ReShape Lifesciences Agrees With Academy Medical To Provide Reshape Balloon To Department Of Defense Facilities

* RESHAPE LIFESCIENCES ANNOUNCES AGREEMENT WITH ACADEMY MEDICAL TO PROVIDE RESHAPE BALLOON AND RESHAPE VBLOC TO DEPARTMENT OF DEFENSE FACILITIES

07 Mar 2018

BRIEF-ReShape Lifesciences Q4 Preliminary Revenue About $795,000

* RESHAPE LIFESCIENCES REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 REVENUE

01 Feb 2018

BRIEF-Endeavour Medtech Growth Reports 10.8 Pct Passive Stake In Reshape Lifesciences Inc

* ENDEAVOUR MEDTECH GROWTH LP REPORTS 10.8 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES INC AS OF DECEMBER 19, 2017 - SEC FILING‍​ Source text for Eikon: (http://bit.ly/2D8uKeR) Further company coverage:

13 Jan 2018

BRIEF-SVLSF IV Reports 14 Pct Passive Stake In Reshape Lifesciences

* SVLSF IV, LLC REPORTS 14 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES AS OF DEC 19 - SEC FILING Source text : (http://bit.ly/2lp7hu7) Further company coverage:

29 Dec 2017

BRIEF-Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​

* RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

13 Dec 2017

BRIEF-Reshape Lifesciences qtrly loss per share $1.06‍​

* Reshape Lifesciences announces third quarter 2017 financial results

15 Nov 2017

BRIEF-Enteromedics Inc says ‍has formally changed its name to Reshape Lifesciences Inc​

* Enteromedics Inc - ‍has formally changed its name to Reshape Lifesciences Inc​ Source text for Eikon: Further company coverage:

23 Oct 2017

Earnings vs. Estimates